Literature DB >> 20202651

Factors associated with delay to medical recognition in two Canadian multiple sclerosis cohorts.

Elaine Kingwell1, Alexander L Leung, Elaine Roger, Pierre Duquette, Peter Rieckmann, Helen Tremlett.   

Abstract

Long referral and diagnostic delays can impact both the opportunity for early therapeutic intervention and estimates of MS incidence and prevalence. We investigated factors associated with diagnostic or referral delays within two geographically distinct MS Canadian cohorts and the association between referral delay and disability at first clinic visit. Adult-onset MS patients were selected from the population-based British Columbian MS (BCMS) (n=5705) and the clinic-based Hôpital Notre-Dame, Quebec (CHUM) (n=1489) databases. Referral delay (BCMS) and diagnostic delay (CHUM) were examined by sex, onset age, disease course (primary progressive (PPMS) vs. relapsing at onset), onset symptoms (BCMS only) and year of first clinic visit/diagnosis. Cohorts were analyzed separately by stratified analyses and multivariable linear modeling. The relationship between referral delay and initial disability was examined by multiple ordinal regression in the BCMS cohort. Younger at onset patients or those with PPMS exhibited significantly longer delays (p<0.001). Delays decreased over the 20+ year period, but reductions varied by clinical course, onset age and sex. Long referral delays were associated with greater disability at first clinic visit (p<0.001). If early intervention at mild disability levels is warranted in MS, then the extended delays to medical recognition for young adult-onset and PPMS patients must be addressed. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20202651     DOI: 10.1016/j.jns.2010.02.007

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  13 in total

Review 1.  The tension between early diagnosis and misdiagnosis of multiple sclerosis.

Authors:  Andrew J Solomon; John R Corboy
Journal:  Nat Rev Neurol       Date:  2017-08-11       Impact factor: 42.937

2.  Hindsight is 20/20.

Authors:  Alexander T Moffett; Harry Hollander; Gail Berkenblit; Justin C McArthur; Reza Manesh
Journal:  J Hosp Med       Date:  2020-02-11       Impact factor: 2.960

3.  The Prevalence of Bipolar Disorders and Association With Quality of Life in a Cohort of Patients With Multiple Sclerosis.

Authors:  Adalia H Jun-O'Connell; Ankur Butala; Idanis Berrios Morales; Nils Henninger; Kristina M Deligiannidis; Nancy Byatt; Carolina Ionete
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2016-08-19       Impact factor: 2.198

4.  Impact of social and clinical factors on the diagnostic delay of chronic kidney disease: an evaluation study.

Authors:  Mousa Ghelichi-Ghojogh; Mohammad Fararouei; Mozhgan Seif; Bahram Shahryari; Maryam Pakfetrat
Journal:  Int Urol Nephrol       Date:  2021-10-28       Impact factor: 2.370

5.  Dramatically changing rates and reasons for hospitalization in multiple sclerosis.

Authors:  Ruth Ann Marrie; Lawrence Elliott; James Marriott; Michael Cossoy; James Blanchard; Aruni Tennakoon; Nancy Yu
Journal:  Neurology       Date:  2014-08-01       Impact factor: 9.910

Review 6.  Incidence and prevalence of multiple sclerosis in Europe: a systematic review.

Authors:  Elaine Kingwell; James J Marriott; Nathalie Jetté; Tamara Pringsheim; Naila Makhani; Sarah A Morrow; John D Fisk; Charity Evans; Sarah Gabrielle Béland; Sophie Kulaga; Jonathan Dykeman; Christina Wolfson; Marcus W Koch; Ruth Ann Marrie
Journal:  BMC Neurol       Date:  2013-09-26       Impact factor: 2.474

7.  Early recognition of multiple sclerosis using natural language processing of the electronic health record.

Authors:  Herbert S Chase; Lindsey R Mitrani; Gabriel G Lu; Dominick J Fulgieri
Journal:  BMC Med Inform Decis Mak       Date:  2017-02-28       Impact factor: 2.796

8.  Risk of Premenopausal and Postmenopausal Breast Cancer among Multiple Sclerosis Patients.

Authors:  Mohammadhossein Hajiebrahimi; Scott Montgomery; Sarah Burkill; Shahram Bahmanyar
Journal:  PLoS One       Date:  2016-10-24       Impact factor: 3.240

9.  Factors associated with time from first-symptoms to diagnosis and treatment initiation of Multiple Sclerosis in Switzerland.

Authors:  Marco Kaufmann; Jens Kuhle; Milo A Puhan; Christian P Kamm; Andrew Chan; Anke Salmen; Jürg Kesselring; Pasquale Calabrese; Claudio Gobbi; Caroline Pot; Nina Steinemann; Stephanie Rodgers; Viktor von Wyl
Journal:  Mult Scler J Exp Transl Clin       Date:  2018-12-06

10.  A population-based study comparing multiple sclerosis clinic users and non-users in British Columbia, Canada.

Authors:  K A McKay; H Tremlett; F Zhu; L Kastrukoff; R A Marrie; E Kingwell
Journal:  Eur J Neurol       Date:  2016-03-15       Impact factor: 6.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.